High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

BACKGROUND/AIMS: The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited. The risk of TB reactivation on IFX and its predictors in patients with IBD was assessed. METHODS: This re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intest Res
Main Authors: Agarwal, Ashish, Kedia, Saurabh, Jain, Saransh, Gupta, Vipin, Bopanna, Sawan, Yadav, Dawesh P, Goyal, Sandeep, Mouli, Venigalla Pratap, Dhingra, Rajan, Makharia, Govind, Ahuja, Vineet
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Association for the Study of Intestinal Diseases 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6223459/
https://ncbi.nlm.nih.gov/pubmed/30301331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2018.00023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados